This country’s economic strategy must include the health of the workforce, and that requires accountability for how funding is spent. Read full story

Both groups lauded the introduction of Bill S-5, which requires that digital health data be shareable across different technology systems, this past winter. CMA past president Dr. Margot Burnell says her organization has been lobbying for this type of legislation for decades. Read full story

If Canada wants to become a global leader in health AI, it should also become a global leader in demonstrating that 'privacy-preserving' AI actually preserves privacy. Read full story

As global health threats become more complex and interconnected, Canada can strengthen health security at home and abroad by investing in locally led research and scientific partnerships. Read full story

If Canada is serious about pharmaceutical sovereignty and supply chain resilience, it must adopt a whole-of-sector approach.  Read full story

This country has ample creativity and invention, but we’ve been chronically ineffective in actually adopting innovative new products and services. Read full story

Canada abstained from a March 2026 United Nations vote condemning the trans-Atlantic enslavement of Africans as ‘the gravest crime against humanity.’ That abstention was not symbolic, it was policy, write members of the Interim Committee on HIV among Black Communities in Canada. Read full story

The future of this country will be shaped not only by the challenges we face today, but how we invest in the children who will inherit them. Parliament must move swiftly to pass Bill S-212 and create a national strategy for children and youth. Read full story

A series of funding deals will expire next March and premiers are urging that those be renewed. 'My hope is that we can reach a solution quickly, put the health issue behind us, [and] have certainty for our own budgeting processes,' said B.C. Premier David Eby. Read full story

The federally appointed group’s report released on July 24 says the multi-year process between Health Canada’s approval and drug pricing negotiations is contributing to companies ‘deprioritizing Canada for product launches.’ Read full story